Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.

CONTEXT Maternal obesity is associated with high plasma triglyceride, poor vascular function, and an increased risk for pregnancy complications. In normal-weight pregnant women, higher triglyceride is associated with increased small, dense low-density lipoprotein (LDL). HYPOTHESIS In obese pregnancy, increased plasma triglyceride concentrations result in triglyceride enrichment of very low-density lipoprotein-1 particles and formation of small dense LDL via lipoprotein lipase. DESIGN Women (n = 55) of body mass index of 18-46 kg/m(2) were sampled longitudinally at 12, 26, and 35 weeks' gestation and 4 months postnatally. SETTING Women were recruited at hospital antenatal appointments, and study visits were in a clinical research suite. OUTCOME MEASURES Plasma concentrations of lipids, triglyceride-rich lipoproteins, lipoprotein lipase mass, estradiol, steroid hormone binding globulin, insulin, glucose, leptin, and adiponectin were determined. RESULTS Obese women commenced pregnancy with higher plasma triglyceride, reached the same maximum, and then returned to higher postnatal levels than normal-weight women. Estradiol response to pregnancy (trimester 1-3 incremental area under the curve) was positively associated with plasma triglyceride response (r(2) adjusted 25%, P < .001). In the third trimester, the proportion of small, dense LDL was 2-fold higher in obese women than normal-weight women [mean (SD) 40.7 (18.8) vs 21.9 (10.9)%, P = .014], and 35% of obese, 14% of overweight, and none of the normal-weight women displayed an atherogenic LDL subfraction phenotype. The small, dense LDL mass response to pregnancy was inversely associated with adiponectin response (17%, P = .013). CONCLUSIONS Maternal obesity is associated with an atherogenic LDL subfraction phenotype and may provide a mechanistic link to poor vascular function and adverse pregnancy outcome.

[1]  Gregory F. Pfister,et al.  “Hot spot” contention and combining in multistage interconnection networks , 1985, IEEE Transactions on Computers.

[2]  M. L. Simmons,et al.  A close look at vector performance of register-to-register vector computers and a new model , 1987, SIGMETRICS '87.

[3]  David H. Bailey,et al.  Vector Computer Memory Bank Contention , 1987, IEEE Transactions on Computers.

[4]  Yousef Saad,et al.  A benchmark package for sparse matrix computations , 1988, ICS '88.

[5]  William Jalby,et al.  Impact of Hierarchical Memory Systems On Linear Algebra Algorithm Design , 1988 .

[6]  Donald A. Calahan Performance evaluation of static and dynamic memory systems on the Cray-2 , 1988, ICS '88.

[7]  Dennis Gannon,et al.  On the problem of optimizing data transfers for complex memory systems , 1988, ICS '88.

[8]  Allen D. Malony,et al.  Performance prediction of loop constructs on multiprocessor hierarchical-memory systems , 1989, ICS '89.

[9]  V. Carstairs,et al.  Deprivation and mortality: an alternative to social class? , 1989, Community medicine.

[10]  J Shepherd,et al.  Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. , 1990, Atherosclerosis.

[11]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[12]  J. Larner,et al.  Measurement of estradiol-17-fatty acid esters in human tissues. , 1992, The Journal of clinical endocrinology and metabolism.

[13]  F. Sacks,et al.  Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. , 1993, The Journal of clinical investigation.

[14]  J. Joven,et al.  Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. , 1993, Journal of lipid research.

[15]  C. Packard,et al.  Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  C. Packard,et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.

[17]  A. Hamsten,et al.  Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Packard,et al.  Lipoprotein heterogeneity and apolipoprotein B metabolism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  C. Packard,et al.  Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. , 1997, The Journal of clinical endocrinology and metabolism.

[20]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[21]  W H Dietz,et al.  Role of the prenatal environment in the development of obesity. , 1998, The Journal of pediatrics.

[22]  N. Sattar,et al.  Leptin levels in pregnancy, marker for fat accumulation and mobilization? , 1998, Acta obstetricia et gynecologica Scandinavica.

[23]  L. Pereira-leite,et al.  Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. , 2002, Atherosclerosis.

[24]  W. Ferrell,et al.  Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. , 2002, The Journal of clinical endocrinology and metabolism.

[25]  T. O'brien,et al.  Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview , 2003, Epidemiology.

[26]  J. Graham,et al.  Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. , 2003, Clinical chemistry.

[27]  G. Targher,et al.  Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals , 2004, Clinical endocrinology.

[28]  M. Hayden,et al.  Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[29]  A. Saiki,et al.  Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. , 2007, Diabetes research and clinical practice.

[30]  W. Ferrell,et al.  Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  Vivian A Schutt,et al.  Liver diseases unique to pregnancy. , 2007, Best practice & research. Clinical gastroenterology.

[32]  S. Dufour,et al.  Intrahepatic Fat Accumulation and Alterations in Lipoprotein Composition in Obese Adolescents , 2007, Diabetes Care.

[33]  H. Mabuchi,et al.  Serum lipoprotein lipase mass: clinical significance of its measurement. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[34]  B. S. Mohammed,et al.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women , 2008, International Journal of Obesity.

[35]  M. Rizzo,et al.  Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[36]  N. Sattar,et al.  Lipoprotein metabolism and vascular complications in pregnancy , 2009 .

[37]  B. Horta,et al.  Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta‐analysis , 2009, Obesity Reviews.

[38]  S. Taylor-Robinson,et al.  Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes , 2011, Diabetologia.

[39]  J. Ramsay,et al.  Obstetric management of obesity in pregnancy. , 2010, Seminars in fetal & neonatal medicine.

[40]  G. La Torre,et al.  Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[41]  N. Sattar,et al.  Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring , 2010, Clinical science.

[42]  L. Shulman A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619 323 births, 1989–2007 , 2010 .

[43]  C. Summerbell,et al.  A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619 323 births, 1989–2007 , 2010, International Journal of Obesity.

[44]  C. Buechler,et al.  Adiponectin, a key adipokine in obesity related liver diseases. , 2011, World journal of gastroenterology.

[45]  V. K. Misra,et al.  The Influence of Overweight and Obesity on Longitudinal Trends in Maternal Serum Leptin Levels During Pregnancy , 2011, Obesity.

[46]  杉野 郁美 Influence of fatty liver on plasma small, dense LDL-cholesterol in subjects with and without metabolic syndrome , 2011 .

[47]  F. Karpe,et al.  Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation , 2011, Diabetes.

[48]  Y. Bacq Liver diseases unique to pregnancy: a 2010 update. , 2011, Clinics and research in hepatology and gastroenterology.

[49]  Ikumi Sugino,et al.  Influence of fatty liver on plasma small, dense LDL- cholesterol in subjects with and without metabolic syndrome. , 2011, Journal of atherosclerosis and thrombosis.

[50]  L. Hodson,et al.  Preeclampsia Is Associated With Compromised Maternal Synthesis of Long-Chain Polyunsaturated Fatty Acids, Leading to Offspring Deficiency , 2012, Hypertension.

[51]  G. Aragonès,et al.  Small artery dilation and endothelial markers in cardiovascular risk patients , 2012, European journal of clinical investigation.

[52]  Dennis Gannon,et al.  Strategies for cache and local memory management by global program transformation , 1988, J. Parallel Distributed Comput..